April 9th, 2015
Selections from Richard Lehman’s Literature Review: April 9th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include the PROMISE trial, the efficacy of folic acid therapy in primary prevention of stroke among patients with hypertension in China, and more.
March 24th, 2015
FDA Grants Premarket Approval to AbioMed Heart Pump
Larry Husten, PHD
The FDA said on Tuesday that it had approved Abiomed’s Impella 2.5 System. According to the company, it is is the first hemodynamic support device to gain FDA approval for use during high risk PCI procedures. The miniature blood pump is designed for temporary use in patients with severe symptomatic coronary artery disease and diminished (but stable) […]
March 16th, 2015
Better Than BEST? An Observational Comparison of PCI and CABG for Multivessel Coronary Disease
Sripal Bangalore, MD, MHA
Sripal Bangalore discusses his observational study comparing CABG with everolimus-eluting stent PCI in patients with multivessel coronary disease, alongside findings from the BEST randomized trial.
January 26th, 2015
Measuring FFR During Cardiac Cath: Time to Go with the Flow?
John Ryan, MD
Is fractional flow reserve being overused, underused, or neither?
October 27th, 2014
Case: When an “Inappropriate” Stress Test Might Be Appropriate
Jean-Pierre Usdin, MD and James Fang, MD
Jean-Pierre Usdin presents the case of a 58-year-old man with well-treated hypertension who experiences an ST-segment-elevation MI shortly after a stress test he had requested to clear him for exercise.
October 13th, 2014
Selections from Richard Lehman’s Literature Review: October 13th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include a comparison of once-weekly dulaglutide and once-daily liraglutide in metformin-treated patients with type 2 diabetes and variation in patients’ perceptions of elective PCI in stable CAD.
September 17th, 2014
Is It Safe to Offer PCI at VA Centers Without On-Site Cardiothoracic Surgery?
Thomas Maddox, MD MSc
Thomas M. Maddox discusses his research group’s study of post-PCI outcomes at VA centers with or without on-site cardiothoracic surgery.
September 3rd, 2014
FAME 2 at 2 Years: Better with Time?
CardioExchange Editors, Staff
The CardioExchange editors ask whether the 2-year findings from FAME 2 are more compelling than the 7-month findings.
September 1st, 2014
Selections from Richard Lehman’s Literature Review: September 1st
Richard Lehman, BM, BCh, MRCGP
This week’s topics include aortic valve stenosis, presenting the benefits of PCI to patients, and more.
August 18th, 2014
Selections from Richard Lehman’s Literature Review: August 18th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include the three sodium studies from NEJM, the CLARIFY study, and more.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?